Significantly lower levels of sRAGE have been described in patients with hypercholesterolemia, hypertension, chronic obstructive pulmonary disease, Alzheimer’s disease, and vascular dementia [56,57,58,59]. This evidence concerns the gene AGER and early-onset autosomal dominant Alzheimer disease.